melatonin has been researched along with vorinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Choi, KC; Jung, JH; Kim, H; Kim, SH; Kwak, S; Park, SH; Song, JH; Sung, GJ | 1 |
| Abdel-Halim, M; Boettcher, S; El-Hady, AK; Gbahou, F; Helmi, YY; Jockers, R; Jung, M; Labani, N; Papenkordt, N; Rennar, G; Schmidtkunz, K; Zlotos, DP | 1 |
3 other study(ies) available for melatonin and vorinostat
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Female; Glioblastoma; Humans; Melatonin; Mice; Mice, Nude; Neoplastic Stem Cells; Polymerization; Vorinostat; Xenograft Model Antitumor Assays | 2019 |
Melatonin-vorinostat hybrid ligands show higher histone deacetylase and cancer cell growth inhibition than vorinostat.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase 1; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Ligands; Melatonin; Neoplasms; Structure-Activity Relationship; Vorinostat | 2023 |